These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of human cytomegalovirus protease by enedione derivatives of thieno[2,3-d]oxazinones through a novel dual acylation/alkylation mechanism. Pinto IL; Jarvest RL; Clarke B; Dabrowski CE; Fenwick A; Gorczyca MM; Jennings LJ; Lavery P; Sternberg EJ; Tew DG; West A Bioorg Med Chem Lett; 1999 Feb; 9(3):449-52. PubMed ID: 10091700 [TBL] [Abstract][Full Text] [Related]
3. The herpesvirus protease: mechanistic studies and discovery of inhibitors of the human cytomegalovirus protease. Flynn DL; Becker DP; Dilworth VM; Highkin MK; Hippenmeyer PJ; Houseman KA; Levine LM; Li M; Moormann AE; Rankin A; Toth MV; Villamil CI; Wittwer AJ; Holwerda BC Drug Des Discov; 1997 May; 15(1):3-15. PubMed ID: 9332827 [TBL] [Abstract][Full Text] [Related]
4. Antiviral drug discovery targeting to viral proteases. Hsu JT; Wang HC; Chen GW; Shih SR Curr Pharm Des; 2006; 12(11):1301-14. PubMed ID: 16611117 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of thieno[2,3-d]oxazines and thieno[2,3-d]thiazines as subtype specific kainate receptor antagonists. Briel D; Rybak A; Mann S; Kronbach C; Unverferth K Curr Med Chem; 2009; 16(35):4704-11. PubMed ID: 19903139 [TBL] [Abstract][Full Text] [Related]
6. The herpesvirus proteases as targets for antiviral chemotherapy. Waxman L; Darke PL Antivir Chem Chemother; 2000 Jan; 11(1):1-22. PubMed ID: 10693650 [TBL] [Abstract][Full Text] [Related]
7. Selective nonpeptidic inhibitors of herpes simplex virus type 1 and human cytomegalovirus proteases. Matsumoto M; Misawa S; Chiba N; Takaku H; Hayashi H Biol Pharm Bull; 2001 Mar; 24(3):236-41. PubMed ID: 11256477 [TBL] [Abstract][Full Text] [Related]
8. Non-nucleoside inhibitors of herpesviruses. Wathen MW Rev Med Virol; 2002; 12(3):167-78. PubMed ID: 11987142 [TBL] [Abstract][Full Text] [Related]
10. Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases. Nitsche C; Steuer C; Klein CD Bioorg Med Chem; 2011 Dec; 19(24):7318-37. PubMed ID: 22094280 [TBL] [Abstract][Full Text] [Related]
14. (D)- and (L)-cyclohexenyl-G, a new class of antiviral agents: synthesis, conformational analysis, molecular modeling, and biological activity. Wang J; Froeyen M; Hendrix C; Andrei C; Snoeck R; Lescrinier E; De Clercq E; Herdewijn P Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):727-30. PubMed ID: 11563102 [TBL] [Abstract][Full Text] [Related]
15. Phenylalanine and Phenylglycine Analogues as Arginine Mimetics in Dengue Protease Inhibitors. Weigel LF; Nitsche C; Graf D; Bartenschlager R; Klein CD J Med Chem; 2015 Oct; 58(19):7719-33. PubMed ID: 26367391 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiviral activity of HCV NS3/4A peptidomimetic boronic acid inhibitors. Boloor A; Hanway D; Joshi M; Winn DT; Mendez G; Walls M; Wei P; Qian F; Zhang X; Zhang Y; Hepperle ME; Li X; Campbell DA; Betancort JM Bioorg Med Chem Lett; 2009 Oct; 19(19):5708-11. PubMed ID: 19713109 [TBL] [Abstract][Full Text] [Related]
17. Pyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: potency and plasma stability. Borthwick AD; Exall AM; Haley TM; Jackson DL; Mason AM; Weingarten GG Bioorg Med Chem Lett; 2002 Jul; 12(13):1719-22. PubMed ID: 12067545 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides. Balzarini J; McGuigan C Biochim Biophys Acta; 2002 Jul; 1587(2-3):287-95. PubMed ID: 12084470 [TBL] [Abstract][Full Text] [Related]
19. Anti-herpesvirus activities and cytotoxicities of 2-thiopyrimidine nucleoside analogues in vitro. Shigeta S; Mori S; Kira T; Takahashi K; Kodama E; Konno K; Nagata T; Kato H; Wakayama T; Koike N; Saneyoshi M Antivir Chem Chemother; 1999 Jul; 10(4):195-209. PubMed ID: 10480738 [TBL] [Abstract][Full Text] [Related]